DADS - Dissecting agitation in dementia by multimodal sensing (DADS)
From 01-10-2023 to 30-09-2027
Description
With age as the leading risk factor for most forms of dementia, an aging population in Belgium, Europe, and worldwide, means an increase in the number of people with dementia (PwD). It is estimated that 136,624 people in Flanders have dementia, a number that is estimated to double by 20601. Globally, there are currently over 50 million PwD, a number expected to reach 82 million in 2030 and triple to 152 million in 20502. The added costs of dementia, now around 1 trillion US dollars a year, are also forecast to be doubled by 20302. Dementia is now the leading cause of death in Belgium3.
Dementia is characterised by a loss of cognitive functioning (memory, language, judgement, etc.). However, behavioural and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms, are as clinically relevant as their cognitive counterparts. BPSD are common in every type of dementia (Alzheimer's disease, vascular, frontotemporal, Lewy Body, Parkinson, etc.), and almost all PwD will develop BPSD during their disease4. BPSD are associated with faster cognitive decline and progression of dementia5,6, lower quality of life of patients7,8, and a substantial increase in caregiver burden9,10. BPSD is the most important factor in eventual institutionalisation, ahead of the cognitive decline itself11,12. Thus, BPSD leads to increased health care and economic costs.
Team
- Maarten De Vos, Promoter
Financing
Funding: KU Leuven - Internal Funding KU Leuven
Program/Grant Type: C2 - KU Leuven Category 2 Funding
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.